Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction

Area of Science:

• Biochemistry
• Physiology
• Pathology

Background:

• Diabetic complications arise from multifactorial causes, with sorbitol metabolism and glycation implicated in vascular and neural dysfunction.
• Elevated sorbitol pathway activity and non-enzymatic glycation products contribute to vascular structural changes in diabetes.

Purpose of the Study:

• To investigate the mechanisms underlying vascular dysfunction in diabetes.
• To assess the role of biochemical imbalances, specifically sorbitol metabolism and glycation, in mediating vascular dysfunction.

Main Methods:

• Utilized three animal models: streptozotocin-induced diabetes in rats, acute hyperglycemia in non-diabetic rats, and a skin chamber model.
• Assessed vascular function via microsphere quantification of blood flow and albumin permeation using radiolabeled albumin.

Main Results:

• Inhibitors of sorbitol metabolism, nitric oxide synthesis, and prostaglandin synthesis prevented glucose-induced vascular dysfunction.
• Superoxide dismutase, probucol, and nitric oxide synthase inhibitors ameliorated dysfunction caused by high glucose and glycated albumin in the skin chamber model.

Conclusions:

• Vascular dysfunction from elevated glucose and glycation involves a common pathway initiated by increased superoxide production.
• This pathway involves increased intracellular calcium, nitric oxide synthesis, leading to enhanced blood flow and vascular permeability.